Viewing Study NCT00323492


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2026-01-29 @ 10:04 PM
Study NCT ID: NCT00323492
Status: COMPLETED
Last Update Posted: 2010-01-20
First Post: 2006-05-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada
Sponsor: Gilead Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GS-FR-164-0109
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Camille Aubron-Olivier
Old Organization: Gilead Sciences

Collaborators